FRLN
Income statement / Annual
Last year (2022), Freeline Therapeutics Holdings plc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Freeline Therapeutics Holdings plc's net income was -$88.97 M.
See Freeline Therapeutics Holdings plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.74 M
|
$2.39 M
|
$1.93 M
|
$1.55 M
|
$0.00
|
| Gross Profit |
-$1.74 M
|
-$2.39 M
|
-$1.93 M
|
-$1.55 M
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$66.20 M
|
$95.43 M
|
$76.15 M
|
$47.04 M
|
$34.19 M
|
| General & Administrative Expenses |
$30.66 M
|
$44.57 M
|
$26.30 M
|
$16.60 M
|
$6.79 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$30.66 M
|
$44.57 M
|
$26.30 M
|
$16.60 M
|
$6.79 M
|
| Other Expenses |
-$1.57 M
|
-$2.09 M
|
-$15.27 M
|
-$10.60 M
|
-$390.00 K
|
| Operating Expenses |
$95.29 M
|
$137.91 M
|
$87.18 M
|
$53.05 M
|
$32.72 M
|
| Cost And Expenses |
$95.29 M
|
$137.91 M
|
$87.18 M
|
$53.05 M
|
$32.72 M
|
| Interest Income |
$904.00 K
|
$403.95 K
|
$275.00 K
|
$74.31 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$151.00 K
|
| Depreciation & Amortization |
$1.27 M
|
$9.24 M
|
$17.18 M
|
$12.14 M
|
$970.00 K
|
| EBITDA |
-$97.17 M |
-$133.14 M |
-$85.27 M |
-$51.51 M |
-$32.14 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.84 M
|
$2.33 M
|
$6.26 M
|
$9.88 M
|
-$470.80 K
|
| Income Before Tax |
-$88.60 M
|
-$140.05 M
|
-$96.19 M
|
-$53.77 M
|
-$33.26 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$368.00 K
|
$342.00 K
|
$129.00 K
|
$141.00 K
|
$27.00 K
|
| Net Income |
-$88.97 M
|
-$140.39 M
|
-$96.32 M
|
-$53.91 M
|
-$33.28 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-22.52 |
-58.98 |
-102.09 |
-127.39 |
-78.65 |
| EPS Diluted |
-22.52 |
-58.98 |
-102.09 |
-127.39 |
-78.65 |
| Weighted Average Shares Out |
$3.95 M
|
$2.38 M
|
$943.52 K
|
$423.19 K
|
$423.19 K
|
| Weighted Average Shares Out Diluted |
$3.95 M
|
$2.38 M
|
$943.52 K
|
$423.19 K
|
$423.19 K
|
| Link |
|
|
|
|
|
